Exercise training and antioxidant supplementation independently improve cognitive function in adult male and female GFAP-APOE mice

Journal of Sport and Health Science

Volumn 3, Issue 3, 2014, Pages 196-205

  Chaudhari, Kiran ^a   Wong, Jessica M ^a   Vann, Philip H ^a   Sumien, Nathalie ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Alzheimer's disease; Antioxidant; Apolipoprotein E; Cognition; Exercise; Vitamin C; Vitamin E; Water maze

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN E; ASCORBIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; WATER;

ADULT; AFFECT; ANIMAL EXPERIMENT; ANXIETY; APTITUDE TEST; ARTICLE; AVOIDANCE BEHAVIOR; COGNITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFECT; EXERCISE; FEMALE; FUNCTIONAL STATUS; GENOTYPE; LEARNING; MALE; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEDENTARY LIFESTYLE; TASK PERFORMANCE; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

EID: 84906267311     PISSN: 20952546     EISSN: 22132961     Source Type: Journal    
DOI: 10.1016/j.jshs.2014.04.004     Document Type: Article

References (76)

1. Arendt T. Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization. Neuroscience 2001, 102:723-765.
2. van Meer P., Acevedo S., Raber J. Impairments in spatial memory retention of GFAP-apoE4 female mice. Behav Brain Res 2007, 176:372-375.
3. Genin E., Hannequin D., Wallon D., Sleegers K., Hiltunen M., Combarros O., et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 2011, 16:903-907.
4. Kim J., Basak J.M., Holtzman D.M. The role of apolipoprotein E in Alzheimer's disease. Neuron 2009, 63:287-303.
5. Blacker D., Haines J.L., Rodes L., Terwedow H., Go R.C., Harrell L.E., et al. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology 1997, 48:139-147.
6. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
7. Craft S., Teri L., Edland S.D., Kukull W.A., Schellenberg G., McCormick W.C., et al. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology 1998, 51:149-153.
8. Martins C.A., Oulhaj A., de Jager C.A., Williams J.H. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Neurology 2005, 65:1888-1893.
9. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278:1349-1356.
10. Molero A.E., Pino-Ramirez G., Maestre G.E. Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-epsilon4 allele in Latin Americans: findings from the Maracaibo Aging Study. Neurosci Lett 2001, 307:5-8.
11. Mortensen E.L., Hogh P. A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 2001, 57:89-95.
12. Raber J., Wong D., Buttini M., Orth M., Bellosta S., Pitas R.E., et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc Natl Acad Sci USA 1998, 95:10914-10919.
13. Reitz C., Mayeux R. Endophenotypes in normal brain morphology and Alzheimer's disease: a review. Neuroscience 2009, 164:174-190.
14. Bour A., Grootendorst J., Vogel E., Kelche C., Dodart J.C., Bales K., et al. Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks. Behav Brain Res 2008, 193:174-182.
15. Acevedo S.F., Piper B.J., Craytor M.J., Benice T.S., Raber J. Apolipoprotein E4 and sex affect neurobehavioral performance in primary school children. Pediatr Res 2010, 67:293-299.
16. Alexander D.M., Williams L.M., Gatt J.M., Dobson-Stone C., Kuan S.A., Todd E.G., et al. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. Biol Psychol 2007, 75:229-238.
17. Dennis N.A., Browndyke J.N., Stokes J., Need A., Burke J.R., Welsh-Bohmer K.A., et al. Temporal lobe functional activity and connectivity in young adult APOE ε4 carriers. Alzheimers Dement 2010, 6:303-311.
18. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004, 101:284-289.
19. Moreau P.H., Bott J.B., Zerbinatti C., Renger J.J., Kelche C., Cassel J.C., et al. ApoE4 confers better spatial memory than apoE3 in young adult hAPP-Yac/apoE-TR mice. Behav Brain Res 2013, 243:1-5.
20. Jochemsen H.M., Muller M., van der Graaf Y., Geerlings M.I. APOE epsilon4 differentially influences change in memory performance depending on age. The SMART-MR study. Neurobiol Aging 2012, 33:832. e15-22.
21. Puttonen S., Elovainio M., Kivimaki M., Lehtimaki T., Keltikangas-Jarvinen L. The combined effects of apolipoprotein E polymorphism and low-density lipoprotein cholesterol on cognitive performance in young adults. Neuropsychobiology 2003, 48:35-40.
22. Yu Y.W., Lin C.H., Chen S.P., Hong C.J., Tsai S.J. Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers. Neurosci Lett 2000, 294:179-181.
23. Grootendorst J., Bour A., Vogel E., Kelche C., Sullivan P.M., Dodart J.C., et al. Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior. Behav Brain Res 2005, 159:1-14.
24. Belinson H., Lev D., Masliah E., Michaelson D.M. Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits. J Neurosci 2008, 28:4690-4701.
25. Fotuhi M., Zandi P.P., Hayden K.M., Khachaturian A.S., Szekely C.A., Wengreen H., et al. Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County Study. Alzheimers Dement 2008, 4:223-227.
26. Harrison F.E., Allard J., Bixler R., Usoh C., Li L., May J.M., et al. Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice. Nutr Neurosci 2009, 12:203-218.
27. Maxwell C.J., Hicks M.S., Hogan D.B., Basran J., Ebly E.M. Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia. Dement Geriatr Cogn Disord 2005, 20:45-51.
28. Head E., Nukala V.N., Fenoglio K.A., Muggenburg B.A., Cotman C.W., Sullivan P.G. Effects of age, dietary, and behavioral enrichment on brain mitochondria in a canine model of human aging. Exp Neurol 2009, 220:171-176.
29. Adlard P.A., Perreau V.M., Pop V., Cotman C.W. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci 2005, 25:4217-4221.
30. Bugg J.M., Head D. Exercise moderates age-related atrophy of the medial temporal lobe. Neurobiol Aging 2011, 32:506-514.
31. Erickson K.I., Voss M.W., Prakash R.S., Basak C., Szabo A., Chaddock L., et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 2011, 108:3017-3022.
32. Garcia-Mesa Y., López-Ramos J.C., Giménez-Llort L., Revilla S., Guerra R., Gruart A., et al. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. J Alzheimers Dis 2011, 24:421-454.
33. Nichol K., Deeny S.P., Seif J., Camaclang K., Cotman C.W. Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice. Alzheimers Dement 2009, 5:287-294.
34. Marosi K., Bori Z., Hart N., Sárga L., Koltai E., Radák Z., et al. Long-term exercise treatment reduces oxidative stress in the hippocampus of aging rats. Neuroscience 2012, 226:21-28.
35. Tayler H., Fraser T., Miners J.S., Kehoe P.G., Love S. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β. J Alzheimers Dis 2010, 22:1363-1373.
36. Zito G., Polimanti R., Panetta V., Ventriglia M., Salustri C., Siotto M.C., et al. Antioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementia. Rejuvenation Res 2013, 16:51-56.
37. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997, 23:134-147.
38. Yasuno F., Tanimukai S., Sasaki M., Ikejima C., Yamashita F., Kodama C., et al. Combination of antioxidant supplements improved cognitive function in the elderly. J Alzheimers Dis 2012, 32:895-903.
39. Corrigan F.M., Van Rhijn A., Horrobin D.F. Essential fatty acids in Alzheimer's disease. Ann N Y Acad Sci 1991, 640:250-252.
40. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 1997, 336:1216-1222.
41. Scarmeas N., Luchsinger J.A., Schupf N., Brickman A.M., Cosentino S., Tang M.X., et al. Physical activity, diet, and risk of Alzheimer disease. JAMA 2009, 302:627-637.
42. Larson E.B., Wang L., Bowen J.D., McCormick W.C., Teri L., Crane P., et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 2006, 144:73-81.
43. Buchman A.S., Boyle P.A., Yu L., Shah R.C., Wilson R.S., Bennett D.A. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology 2012, 78:1323-1329.
44. Liu-Ambrose T., Nagamatsu L.S., Graf P., Beattie B.L., Ashe M.C., Handy T.C. Resistance training and executive functions: a 12-month randomized controlled trial. Arch Intern Med 2010, 170:170-178.
45. Head D., Bugg J.M., Goate A.M., Fagan A.M., Mintun M.A., Benzinger T., et al. Exercise engagement as a moderator of the effects of apoe genotype on amyloid deposition. Arch Neurol 2012, 69:636-643.
46. Brown B.M., Peiffer J.J., Martins R.N. Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer's disease?. Mol Psychiatry 2013, 18:864-874.
47. Obisesan T.O., Umar N., Paluvoi N., Gillum R.F. Association of leisure-time physical activity with cognition by apolipoprotein-E genotype in persons aged 60 years and over: the National Health and Nutrition Examination Survey (NHANES-III). Clin Interv Aging 2012, 7:35-43.
48. Radak Z., Kaneko T., Tahara S., Nakamoto H., Pucsok J., Sasvári M., et al. Regular exercise improves cognitive function and decreases oxidative damage in rat brain. Neurochem Int 2001, 38:17-23.
49. Cetin E., Top E.C., Sahin G., Ozkaya Y.G., Aydin H., Toraman F. Effect of vitamin E supplementation with exercise on cognitive functions and total antioxidant capacity in older people. J Nutr Health Aging 2010, 14:763-769.
50. Devi S.A., Kiran T.R. Regional responses in antioxidant system to exercise training and dietary vitamin E in aging rat brain. Neurobiol Aging 2004, 25:501-508.
51. Jolitha A.B., Subramanyam M.V., Asha Devi S. Modification by vitamin E and exercise of oxidative stress in regions of aging rat brain: studies on superoxide dismutase isoenzymes and protein oxidation status. Exp Gerontol 2006, 41:753-763.
52. Wu A., Ying Z., Gomez-Pinilla F. Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 2008, 155:751-759.
53. Ristow M., Zarse K., Oberbach A., Klöting N., Birringer M., Kiehntopf M., et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA 2009, 106:8665-8670.
54. Su S.H., Chen H., Jen C.J. C57BL/6 and BALB/c bronchoalveolar macrophages respond differently to exercise. J Immunol 2001, 167:5084-5091.
55. Sumien N., Sims M.N., Taylor H.J., Forster M.J. Profiling psychomotor and cognitive aging in four-way cross mice. Age (Dordr) 2006, 28:265-282.
56. Hartman R.E., Wozniak D.F., Nardi A., Olney J.W., Sartorius L., Holtzman D.M. Behavioral phenotyping of GFAP-ApoE3 and -ApoE4 transgenic mice: ApoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Exp Neurol 2001, 170:326-344.
57. Huang Y. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models. Biochem Soc Trans 2011, 39:924-932.
58. Aboud O., Mrak R.E., Boop F.A., Griffin W.S. Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype. Acta Neuropathol Commun 2013, 1:41.
59. Qiu C., Kivipelto M., Aguero-Torres H., Winblad B., Fratiglioni L. Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex. J Neurol Neurosurg Psychiatry 2004, 75:828-833.
60. Keltikangas-Jarvinen L., Raikkonen K., Lehtimaki T. Dependence between apolipoprotein E phenotypes and temperament in children, adolescents, and young adults. Psychosom Med 1993, 55:155-163.
61. Kornecook T.J., McKinney A.P., Ferguson M.T., Dodart J.C. Isoform-specific effects of apolipoprotein E on cognitive performance in targeted-replacement mice overexpressing human APP. Genes Brain Behav 2010, 9:182-192.
62. Reverte I., Klein A.B., Ratner C., Domingo J.L., Colomina M.T. Behavioral phenotype and BDNF differences related to apoE isoforms and sex in young transgenic mice. Exp Neurol 2012, 237:116-125.
63. Sumien N., Heinrich K.R., Shetty R.A., Sohal R.S., Forster M.J. Prolonged intake of coenzyme Q10 impairs cognitive functions in mice. J Nutr 2009, 139:1926-1932.
64. Joshi K., Lad S., Kale M., Patwardhan B., Mahadik S.P., Patni B., et al. Supplementation with flax oil and vitamin C improves the outcome of attention deficit hyperactivity disorder (ADHD). Prostaglandins Leukot Essent Fatty Acids 2006, 74:17-21.
65. Siegel J.A., Haley G.E., Raber J. Apolipoprotein E isoform-dependent effects on anxiety and cognition in female TR mice. Neurobiol Aging 2012, 33:345-358.
66. -/- mice. Neurobiol Aging 2005, 26:637-643.
67. Desrumaux C., Risold P.Y., Schroeder H., Deckert V., Masson D., Athias A., et al. Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice. FASEB J 2005, 19:296-297.
68. Hughes R.N., Lowther C.L., van Nobelen M. Prolonged treatment with vitamins C and E separately and together decreases anxiety-related open-field behavior and acoustic startle in hooded rats. Pharmacol Biochem Behav 2011, 97:494-499.
69. Huebbe P., Jofre-Monseny L., Rimbach G. Alpha-tocopherol transport in the lung is affected by the apoE genotype-studies in transgenic apoE3 and apoE4 mice. IUBMB Life 2009, 61:453-456.
70. Huebbe P., Lodge J.K., Rimbach G. Implications of apolipoprotein E genotype on inflammation and vitamin E status. Mol Nutr Food Res 2010, 54:623-630.
71. Brown B.M., Peiffer J.J., Taddei K., Lui J.K., Laws S.M., Gupta V.B., et al. Physical activity and amyloid-beta plasma and brain levels: results from the Australian imaging, biomarkers and lifestyle study of ageing. Mol Psychiatry 2013, 18:875-881.
72. Schuit A.J., Feskens E.J., Launer L.J., Kromhout D. Physical activity and cognitive decline, the role of the apolipoprotein e4 allele. Med Sci Sports Exerc 2001, 33:772-777.
73. Etnier J.L., Caselli R.J., Reiman E.M., Alexander G.E., Sibley B.A., Tessier D., et al. Cognitive performance in older women relative to ApoE-ε4 genotype and aerobic fitness. Med Sci Sports Exerc 2007, 39:199-207.
74. Tamaoka A., Miyatake F., Matsuno S., Ishii K., Nagase S., Sahara N., et al. Apolipoprotein E allele-dependent antioxidant activity in brains with Alzheimer's disease. Neurology 2000, 54:2319-2321.
75. Pedersen W.A., Chan S.L., Mattson M.P. A mechanism for the neuroprotective effect of apolipoprotein E: isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal. J Neurochem 2000, 74:1426-1433.
76. Ramassamy C., Averill D., Beffert U., Theroux L., Lussier-Cacan S., Cohn J.S., et al. Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. Neurobiol Dis 2000, 7:23-37.